External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience MDS 2025
Roche and Genentech at

MDS 2025

October 05 - October 09
Hawaii, USA
mdscongress.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
10:30 PM
Duration 6mins Honolulu, Hawaii
PADOVA: Topline results from a Phase IIb study of prasinezumab in early-stage Parkinson’s disease participants on stable symptomatic treatment
Tania Nikolcheva
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:00 PM
Duration 3mins Hawaii, USA
Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment
Nathalie Pross
Neuroscience | Parkinson Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.